Effect of daily versus weekly iron and folate therapy on changes in hemoglobin levels
Phase 3
- Conditions
- Health Condition 1: null- anemic patient
- Registration Number
- CTRI/2018/01/011181
- Lead Sponsor
- Dr Sarala Premkumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
11-16 years old anemic children will be included after getting informed consent
Exclusion Criteria
children with chronic medical illness.
those refusing consent
those already on medications
Hb <7gms%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hb recovery percentage is expected to be comparable in both the treatment groups with no significant difference between themTimepoint: Hb recovery percentage is expected to be comparable in both the treatment groups with no significant difference between them.We will ensure to remeasure in week 8 &week16
- Secondary Outcome Measures
Name Time Method Hb recovery percentage is expected to be comparable in both treatment groups with no significant difference between themTimepoint: 8 weeks and 16 weeks